{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Tuberculosis: A New Screening Recommendation and an Expanded Approach to Elimination in the United States

Purpose of Activity

To provide information about newer testing methodologies and shorter treatment regimens for tuberculosis, especially among high-risk groups.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Outline the pathophysiology and epidemiology of tuberculosis.
  2. Identify improvements in identification and changes in treatment regimens for latent tuberculosis infection.
Price: $17.95

Credits:

  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.







Test Code: AJN0817A
Published: Aug 2017
Expires: 8/31/2019
Passing Score: 14/19 (73%)
Authors: John Parmer, PhD, MS, Leeanna Allen, MPH, BS, and Wanda Walton, PhD, MEd
Categories: Infection, Respiratory
Topics: Tuberculosis